lifestyle.capitolhilltimes.com

Category: Press Releases

Monte Rosa Therapeutics to Participate in Upcoming Investor Conferences

February 23, 2026
Harfang Provides Update at Sky Lake

February 23, 2026
Benitec Biopharma Announces Acceptance of Late- Breaking Abstract for the BB-301 Phase 1b/2a Clinical Treatment Study at the Muscular Dystrophy Association Clinical & Scientific Conference

February 23, 2026
Koryx Copper Announces Further Significant Drill Results at the Haib Copper Project, Southern Namibia

February 23, 2026
C4 Therapeutics Announces First Patient Dosed in Phase 2 MOMENTUM Trial of Cemsidomide, an Oral IKZF1/3 Degrader, in Combination with Dexamethasone for Relapsed/Refractory Multiple Myeloma

February 23, 2026
Tessera Therapeutics Receives U.S. FDA Fast Track and Orphan Drug Designations for its Lead In Vivo Gene Editing Program TSRA-196 for the Treatment of Adults with AATD

February 23, 2026
Cartesian Therapeutics to Participate in Upcoming Investor Conferences

February 23, 2026
Aquestive Therapeutics to Participate in Oppenheimer 36th Annual Healthcare Life Sciences Conference

February 23, 2026
PyroGenesis Confirms First Titanium Powder Order with Scientific Aerospace Research Organization

February 23, 2026
Loblaw to invest $2.4 billion in the Canadian economy in 2026, with plans to build 70 new stores and create well over 9,000 jobs

February 23, 2026